Details For Selected Brain Tumor Treatment
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is our internal ID - starting with VT.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment
  • For trials that also have a NCT number, you can click that number to pop up the listing from the website.
Back to New Treatments List Back to New Treatments List

Treatment Name: A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma
Keywords: Tandutinib
Phase: Phase 1/2
Treatment ID#s: VT1766         NCT00379080
Age Group: Adults Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 04/21/2009
Tumor Types: Glioblastoma Multiforme
Comments: RATIONALE: Tandutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
Treatment Type: Less-Toxics
Immunological, Biological or Targeted Therapy.
Contact: Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Clinical Trials Office - University of Alabama at Birmingham
Birmingham, AL 35294
Email not available
Emory University
Jeffrey Olsen
Contact: Dr. Jeffrey Olsen
1327 Clifton Road, NE
Atlanta, GA 30322-
Fax: (404)778-5121
Click here to send an email
Mass. General Hospital - Brain Tumor Center
Tracy Batchelor, MD, MPH
Executive Director
Brain Tumor Center
Suite 315, Cox Building
Boston, MA 02114
Fax: (617)724-8769
Click here to send an email
Johns Hopkins Hospital
Stuart Grossman, MD
Professor of Oncology, Medicine & Neurosurgery
Contact: Stuart Grossman
Bunting & Blaustein Cancer Research Bldg
1650 Orleans Street
Baltimore, MD 21231-1000
Fax: 410-614-9335
Click here to send an email
National Cancer Institute
Cheryl Royce, CRNP, Clinical Director
Neuro-oncology Branch
9030 Old Georgetown Road
Bethesda, MD 20892
Click here to send an email
Henry Ford Hospital
Tom MikKelsen, MD, FRCP(C)
Contact: Dr. Tom Mikelsen
Hermelin Brain Tumor Center
E&R3096 Henry Ford Hospital 2799 West Grand Blvd
Detroit, MI 48202-
Phone:313 916-8641
Fax: 313 916-9855
Click here to send an email
Wake Forest Comprehensive Cancer Center
Judy Lovelace, R.N.
Medical Oncology
Medical Center Blvd.
Winston-Salem, NC 27157
Fax: ( ) -
Click here to send an email
Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center
Gene Barnett, MD
: Professor and Director, Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center
Cleveland, OH 44195
Fax: 216-444-0924
Click here to send an email
Hospital of the Univ. of PA
Steven Brem, MD
3 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Phone:1-800-789-PENN (7366)
Email not available
Abramson Cancer Center
Clinical Trials Office - Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA 19104
Email not available

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites